Literature DB >> 9464215

Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers.

Y Gelfin1, M Gorfine, B Lerer.   

Abstract

OBJECTIVE: The authors sought to determine the effect of clinically equivalent doses of fluoxetine on mood and other psychological variables in normal subjects.
METHOD: Fifteen healthy volunteers received placebo for 2 weeks; fluoxetine, 10 mg/day, for 1 week; fluoxetine, 20 mg/day, for 5 weeks; and then an additional 2 weeks of placebo in the context of a single-blind study. The subjects were evaluated with a series of self- and observer-rated instruments.
RESULTS: No significant effects attributable to fluoxetine were observed on any of the psychological variables examined. Minimal adverse effects were reported.
CONCLUSIONS: Significant mood-elevating and other psychological effects of fluoxetine would appear to be induced only when symptomatic targets exist.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9464215     DOI: 10.1176/ajp.155.2.290

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  17 in total

1.  Effects of antidepressants on the performance in the forced swim test of two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions.

Authors:  Giovanna Piras; Osvaldo Giorgi; Maria G Corda
Journal:  Psychopharmacology (Berl)       Date:  2010-06-30       Impact factor: 4.530

2.  5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats.

Authors:  Ashley Furr; M Danet Lapiz-Bluhm; David A Morilak
Journal:  Int J Neuropsychopharmacol       Date:  2011-10-19       Impact factor: 5.176

3.  Effects of spiritual mantram repetition on HIV outcomes: a randomized controlled trial.

Authors:  Jill E Bormann; Allen L Gifford; Martha Shively; Tom L Smith; Laura Redwine; Ann Kelly; Sheryl Becker; Madeline Gershwin; Patricia Bone; Wendy Belding
Journal:  J Behav Med       Date:  2006-07-18

4.  Effects of chronic antidepressant treatments in a putative genetic model of vulnerability (Roman low-avoidance rats) and resistance (Roman high-avoidance rats) to stress-induced depression.

Authors:  Giovanna Piras; Maria A Piludu; Osvaldo Giorgi; Maria G Corda
Journal:  Psychopharmacology (Berl)       Date:  2013-07-30       Impact factor: 4.530

5.  The effects of sertraline on psychopathic traits.

Authors:  Boadie W Dunlop; Jared A DeFife; Lauren Marx; Steven J Garlow; Charles B Nemeroff; Scott O Lilienfeld
Journal:  Int Clin Psychopharmacol       Date:  2011-11       Impact factor: 1.659

Review 6.  Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.

Authors:  G J H Dumont; S J de Visser; A F Cohen; J M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

7.  Fluoxetine inhibits inflammatory response and bone loss in a rat model of ligature-induced periodontitis.

Authors:  Luciana S Branco-de-Almeida; Gilson C Franco; Myrella L Castro; Juliana G Dos Santos; Ana Lia Anbinder; Sheila C Cortelli; Mikihito Kajiya; Toshihisa Kawai; Pedro L Rosalen
Journal:  J Periodontol       Date:  2011-10-03       Impact factor: 6.993

Review 8.  Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

Authors:  S M Cheer; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

9.  Quality of life of 'normal' controls: association with lifetime history of mental illness.

Authors:  Dianne Schechter; Jean Endicott; John Nee
Journal:  Psychiatry Res       Date:  2007-03-23       Impact factor: 3.222

10.  Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression.

Authors:  Ulla Knorr; Maj Vinberg; Marianne Klose; Ulla Feldt-Rasmussen; Linda Hilsted; Anders Gade; Eva Haastrup; Olaf Paulson; Jørn Wetterslev; Christian Gluud; Ulrik Gether; Lars Kessing
Journal:  Trials       Date:  2009-08-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.